TiGenix Archives

In Depth 8 Oct 2018

Behind the Scenes of the Spanish Biotech Industry’s Boom

The Spanish biotech industry is booming, but from my conversations with industry players elsewhere in Europe, it seems the country’s biotech industry keeps being a mystery for many. I caught…

October 8, 2018 - 5 minutesmins - By Clara Rodríguez Fernández

tigenix alofisel takeda stem cell therapy crohns disease

News and Trends 27 Mar 2018

Stem Cell Therapy for Crohn’s Disease Approved in Europe

Developed by TiGenix, Alofisel is the first stem cell therapy made out of donor stem cells to receive a marketing authorization in Europe. The European Commission has approved Alofisel (darvadstrocel), a stem…

March 27, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

Interview 22 Jan 2018

Bravo! An Interview with the CEO of Takeda’s Recent Cell Therapy Target

I sat down with Eduardo Bravo, CEO of TiGenix, to talk about the technology that made his company so attractive to the pharma giant. After beginning his career in big…

January 22, 2018 - 6 minutesmins - By Evelyn Warner

takeda tigenix acquisition stem cell therapy

News and Trends 5 Jan 2018

Takeda Starts the Year Bidding for a Belgian Stem Cell Therapy Biotech

Takeda has offered to acquire TiGenix subject to the upcoming European approval of its lead stem cell therapy for Crohn's disease, Cx601. Short of two years after partnering with TiGenix…

January 5, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 18 Dec 2017

Belgian Biotech’s Crohn’s Disease Cell Therapy Gets Recommended for Approval

An EMA committee has supported an allogeneic stem cell therapy for the first time, as TiGenix's Crohn's disease candidate is backed for approval. TiGenix and its Japanese partner, Takeda, are developing a…

December 18, 2017 - 3 minutesmins - By Alex Dale

News and Trends 23 Oct 2017

FDA Grants Belgian Crohn’s Disease Candidate Orphan Designation

TiGenix’s candidate for a nasty Crohn’s disease complication received orphan drug designation after agreeing on a global Phase III trial. TiGenix exploits the anti-inflammatory properties of donor-derived stem cells to treat…

October 23, 2017 - 2 minutesmins - By Alex Dale

In Depth 11 Jul 2017

Regenerating the Body With Stem Cells – Hype or Hope?

When the Japanese researcher Shinya Yamanaka managed to reprogram adult cells into an embryonic-like state to yield induced pluripotent stem cells (iPSCs), this was supposed to herald a revolution in…

July 11, 2017 - 9 minutesmins - By Melanie De Almeida

Best in Biotech 15 Mar 2017

What are the Best Countries to Recruit Biotech Talents in 2017?

Before the “who to recruit” phase, an important question is “where?” We ran through the top countries in which to look for talent in biotech and had a look at what…

March 15, 2017 - 10 minutesmins - By External Contributor

Tigenix AlloCSC 01 stem cell therapy AMI

News and Trends 13 Mar 2017

New Cardiac Stem Cell Therapy passes Phase I/II Trials

TiGenix announces positive one-year results for its phase I/II trial of donor-derived cardiac stem cell therapy in acute myocardial infarction (AMI). The Belgian biotech TiGenix is developing allogeneic stem cell therapies. Now the…

March 13, 2017 - 3 minutesmins - By Melanie De Almeida

News and Trends 1 Feb 2017

Stem Cell Therapy for Sepsis in Pneumonia advances to Phase II

TiGenix has treated the first patient in a new early-stage clinical trial to test its candidate Cx611 as a treatment for sepsis in patients with pneumonia. TiGenix, based in Belgium,…

February 1, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

Screenshot 2016 12 07 at 3.46.36 PM e1481122126679

News and Trends 15 Dec 2016

UPDATE: European Stem Cell Therapy Pioneer goes for €34M IPO

TiGenix is entering the Nasdaq with an IPO aimed at funding clinical trials. Will this move allow the company to make it through clinical trials? TiGenix is a Belgian company…

December 15, 2016 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 3 Aug 2016

UPDATED: TiGenix finishes Phase III Stem Cell therapy to treat Crohn’s disease

Belgium is a real pioneer in developing stem cell therapies. TiGenix pushes this precursor position even further by presenting good results from a Phase III of its stem cell therapy…

August 3, 2016 - 3 minutesmins - By Philip Hemme

tigenix takeda stem cell therapy crohns fistula

News and Trends 6 Jul 2016

Takeda snatches up Belgian Cell therapy for Crohn’s Disease

TiGenix is licensing the rights for its cell therapy which is under EMA review and is meant to treat a serious complication of Crohn's disease. This worldwide exclusivity deal (with…

July 6, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 27 Sep 2015

What Happened this Week? Human Embryos Back on the Bench, Stem Cells in your Heart and New Antibiotics

Monday: Nabriva Therapeutics launched its $100M IPO on the NASDAQ to develop new antibiotics Tuesday: the Francis Crick Institute announced its application to conduct new research on human embryos Wednesday: Israeli NovoCure…

September 27, 2015 - 1 minutemin - By Joachim Eeckhout

News and Trends 24 Sep 2015

Heart Attacks: TiGenix advances its cardiac stem-cell therapy

Belgian TiGenix NV released the phase I results of their cardiac stem-cell therapy at the Congress of the European Society of Cardiology (ESC) in London earlier this month. In July, TiGenix…

September 24, 2015 - 3 minutesmins - By Dani Bancroft

Report: new Frontiers in Vaccinology

Listen to our podcast

View all sectors A-Z

The Biotech Perspective 2023

View all companies A-Z

Find new scientific partnerships. Create a free IN-PART account

View all countries A-Z

Report: The European Biotech Startup Ecosystem

Subcribe to our newsletter

Learn more about Inova, the leading platform for biopharma partnering